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Abstract
Background: Avidin is a chicken egg-white protein with high affinity to vitamin H, also known as D-biotin. Many
applications in life science research are based on this strong interaction. Avidin is a homotetrameric protein, which
promotes its modification to symmetrical entities. Dual-chain avidin, a genetically engineered avidin form, has two circularly
permuted chicken avidin monomers that are tandem-fused into one polypeptide chain. This form of avidin enables
independent modification of the two domains, including the two biotin-binding pockets; however, decreased yields in
protein production, compared to wt avidin, and complicated genetic manipulation of two highly similar DNA sequences in
the tandem gene have limited the use of dual-chain avidin in biotechnological applications.
Principal Findings: To overcome challenges associated with the original dual-chain avidin, we developed chimeric dual-
chain avidin, which is a tandem fusion of avidin and avidin-related protein 4 (AVR4), another member of the chicken avidin
gene family. We observed an increase in protein production and better thermal stability, compared with the original dual-
chain avidin. Additionally, PCR amplification of the hybrid gene was more efficient, thus enabling more convenient and
straightforward modification of the dual-chain avidin. When studied closer, the generated chimeric dual-chain avidin
showed biphasic biotin dissociation.
Significance: The improved dual-chain avidin introduced here increases its potential for future applications. This molecule
offers a valuable base for developing bi-functional avidin tools for bioseparation, carrier proteins, and nanoscale adapters.
Additionally, this strategy could be helpful when generating hetero-oligomers from other oligomeric proteins with high
structural similarity.
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Introduction
Improving the performance and accuracy of molecular tools
used in life science research is essential for developing better and
more precise methods. Chicken avidin (AVD) and its bacterial
analogue streptavidin (SA) from Streptomyces avidinii, collectively
called (strept)avidin, are proteins widely used in life science
research applications. (Strept)avidin has been used for quantitative
measurements by radioligand-binding methods [1], enzyme assays
[2,3] and photometric/fluorometric methods [4–6]. AVD has also
been successfully used in biosensors as an immobilization platform
[7]. The specific characteristics of AVD, such as the high positive
charge (pI 10.5) and high biotin-binding affinity (Kd<10
215 M),
have resulted in a number of different drug-targeting applications
that use the (strept)avidin-biotin interaction [8].
Although widely used, (strept)avidin’s homotetrameric struc-
ture restricts its use in some applications. To overcome this
limitation, dual-chain avidin (dcAVD) was generated [9] by
fusing two circularly permuted chicken avidin monomers into one
polypeptide chain. This molecular engineering approach pro-
duced a protein that resembles wt avidin in 3-D structure [10]
but allows independent manipulation of ligand-binding sites
within a single protein particle. To create dual-affinity deriva-
tives, dcAVD was modified by site-directed mutagenesis. This
form of dcAVD exhibited a tight biotin affinity for two binding
sites, whereas the other two binding sites had reduced affinity due
to the mutations [11]. Recently, a point mutation S16C was
targeted into one of the biotin-binding sites of dcAVD [12].
The introduction of a chemically active thiol group into the
binding site made it possible to selectively control the biotin-
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20535binding activity of the dcAVD domains by a mild chemical
treatment.
Despite recent improvements, some challenges that could limit
the use of dcAVD persist. For instance, PCR amplification of the
dcAVD-encoding sequence has been challenging because primers
recognize complementary sequences from both subunits, which
would produce several different PCR products. This same issue
also limits targeted mutagenesis of dcAVD. This study uses a new
approach for developing the dcAVDs. Instead of constructing a
tandem gene by combining two differently circularly permuted
chicken avidins [9] or streptavidins [13], two related avidin genes
were used as building blocks for the chimeric tandem fusion. The
raw materials of the chimeras were selected from a group of
homologous proteins. Streptavidin (SA), the most widely used
protein in biotechnological applications in the avidin family, and
avidin-related proteins 2 and 4 (AVR2 and AVR4) [14,15] were
selected as fusion partners for the circularly permuted chicken
avidin. By combining homologous genes into the chimeric tandem
gene, we were able to address the problems associated with the
original dcAVD. According to our knowledge, this is the first study
showing such forced hybridization of different types of biotin-
binding proteins into an oligomeric assembly.
Results and Discussion
The chimeric dcAVD fusions were designed according to
previously described principles [9]. The loop connecting the
original termini of the circularly permuted SA, AVR4, and
AVR2 was shortened when compared to the original dcAVD,
as presented in Figure 1. This shortening was performed
because the loop was largely invisible in the X-ray analysis of
dcAVD, indicating high mobility of the loop region [10].
Figure 1. The homology model of dcAVD/AVR4 and the sequences of chimeric dcAVDs. The molecular model of dcAVD/AVR4 is
generated by exploiting the existing 3-D structures of the dcAVD and AVR4. In the model, cpAVD is illustrated in light gray, and cpAVR4 is illustrated
in dark gray. Amino acid sequence of cpAVD is in the light gray box, and the amino acid sequences of cpAVR2, cpAVR4, and cpSA are in the dark gray
boxes. The linkers and the corresponding linker sequences connecting the original termini are shown in red. The linkers connecting the circularly
permuted subunits and the corresponding linker sequences are shown in blue. The schematic representation of the protein expression cassette is in
the bottom of the figure.
doi:10.1371/journal.pone.0020535.g001
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Two conditions were used to evaluate performance of the
dcAVD forms in PCR amplification. When primers recognizing
the sequence that flank the tandem fusion gene were used, the
amplification resulted in no notable differences between dcAVD
and chimeric fusions. Amplification of the four dual-chain genes
produced appropriately sized (,1000 bp) PCR products; however,
a shorter product (700 bp) was clearly observed, except for
dcAVD/SA (not shown). The short product could be a result of
the amplification of a self-hybridized tandem gene. No clear
differences were observed for reactions using the different thermal
cycling parameters.
In contrast, when primers recognizing regions inside the tandem
fusion gene were used, a clear difference in the behavior between
dcAVD and the chimeric fusions was detected (Figure 2A). A
number of side products were generated during the PCR
amplification of the dcAVD gene, which was probably due to
primers binding to multiple positions in the tandem gene and
homologous recombination during the amplification process. In
contrast, for the chimeric fusions, only two main PCR products
were detected, which were the appropriately sized products. The
dcAVD/SA showed the most efficient amplification. Using the
chimeric fusion genes significantly improves PCR amplification
and would allow targeting of mutagenesis to only a part of the
gene, such as using the Quik-Change (Stratagene, La Jolla, CA,
US) protocol. Moreover, this would enable the broader modifica-
tion of dcAVD molecules, including targeted random mutagenesis
of several amino acids.
The chimeric fusion dcAVD/AVR4 can be efficiently
expressed in E. coli
All proteins selected as chimeric fusion partners resemble avidin
in their fold and 3-D structure [16–18]. Therefore, we assumed that
chimeric dual-chainavidinscould be produced where one circularly
permuted subunit would be based on the avidin sequence, and the
other subunit would be based on another biotin-binding protein
(AVR2, AVR4, SA). The chimeric dual-chain fusions were
produced in E. coli using the periplasmic signal peptide from the
Bordetella avium ompA protein [19]. The chimeric fusion dcAVD/
AVR4 produced the best levels of the proteins analyzed, and the
protein was almost entirely intact (,35 kDa) after 2-iminobiotin
affinity chromatography (Figure 2B). To further study the usability
of this chimeric protein, a pilot-scale expression of the dcAVD/
AVR4 protein was performed in a 7.5 L fermentor. The pilot-scale
fed-batchfermentationinstandard LBmediumyielded greaterthan
5 mg of pure dcAVD/AVR4 protein per liter of production
medium with low amounts of protein fragments (Figure S1).
When dcAVD/AVR2 and dcAVD/SA proteins were produced,
there was a significant amount of fragmented (,15 kDa) products
in the SDS-PAGE analysis (Figure 2B). The low-sequence identity
of SA with avidin (only ,30%, AVR’s identity with avidin ,80%
[20]) may explain the modest performance during the production of
the chimeric dual-chain fusion with SA. Because some full-length
protein was detected in the SDS-PAGE analysis of dcAVD/SA
(Figure 2B), it might be possible to genetically tune this AVD/SA-
hybrid to enhance its performance. The possible targets for such
optimizations are discussed later in the text.
Figure 2. The performance of the chimeric dual-chain avidins in the PCR analysis and in E. coli expression. The usability of the
generated chimeric dual chain avidin fusions was evaluated by amplifying the fusion genes by PCR and by expressing the proteins in E. coli. A) In the
PCR analysis with primers recognizing regions inside the chimeric dcAVD genes (PCR 2), a clear difference between the behavior of the dcAVD genes
(A) and the chimeric fusion genes (AA2, dcAVD/AVR2; AA4, dcAVD/AVR4; SA, dcAVD/SA) was detected. The chimeric fusion genes showed only two
main PCR products; the appropriately sized product had the highest concentration. When the dcAVD gene was used as a template, several different-
sized products were produced. The results from the PCR2 reaction (see Table S1) from two different conditions (I, II) are shown in the figure. (L, 1 kb
DNA ladder). B) SDS-PAGE analysis of the purified chimeric dcAVDs showed that dcAVD/AVR4 was the most successfully expressed in its functional
form in E. coli. The upper arrowhead indicates the location of the intact protein, and the lower arrowhead indicates the location of the proteolytically
cleaved product. (M, molecular weight standard; AA2, dc-AVD-AVR2; AA4, dc-AVD-AVR4; AS, dc-AVD-SA, bA, chicken avidin control sample (protein
expressed in E. coli [19]); cA, chicken avidin control sample).
doi:10.1371/journal.pone.0020535.g002
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oligomeric state of the produced proteins. The analysis revealed
that the dcAVD/AVR4 protein was mostly in a pseudo-tetrameric
form (Figure S2). Some higher molecular weight species were also
detected, which could be explained by the oligomerization of
pseudo-tetramers often detected in wt avidin samples [19]. Size-
exclusion chromatography analysis of dcAVD/AVR2 revealed a
significant proportion of clearly higher molecular weight species
than dcAVD/AVR4. Interestingly, both dcAVD/SA and
dcAVD/AVR2 appeared mostly in a pseudo-tetrameric form in
gel-filtration analysis (results not shown). This result may indicate
that the truncated protein forms observed in the SDS-PAGE
analysis (Figure 2B) might be able to form oligomeric species,
resulting in homotetrameric proteins. In any case, further studies
are needed to better understand the properties of dcAVD/AVR2
and dcAVD/SA. In this study, dcAVD/AVR4 protein was
selected to further biochemical analyses.
Differences in the subunit interfaces reveal possible
reasons for the characteristics of chimeric dual-chain
avidins
To analyze the possible reasons for the behavioral differences of
the chimeric dual-chain avidins, the fusion proteins were modeled
based on previously determined 3-D structures of dcAVD (PDB
2C4I), SA (PDB 1MK5), and AVRs (AVR2 (PDB 1WBI), AVR4
(PDB 1Y53)). The model of dcAVD/AVR4 is presented in
Figure 1. Molecular dynamics (MD) were performed for the
predicted chimeric dual-chain avidin models. The simulations
were performed in explicit water using the CHARMM force field.
The interaction energy during the MD simulation was measured
between subunits, which is the most obvious region in the structure
that would cause problems in the dcAVD assembly. In the MD
simulation analyses, dcAVD/SA had clearly the least favorable
electrostatic interaction energy (Figure 3A), whereas there were no
significant differences in the van der Waals energies between
chimeric dcAVD forms (Figure 3B). A closer inspection of the MD
simulation data of dcAVD/SA revealed three putative electro-
statically repulsive interactions (Figures 3C and 3D). These
residues (D247-E15-D241, K12-R239 and D27-E165) are poten-
tial targets for further engineering of dcAVD/SA to improve its
characteristics.
To investigate how the chimeric dcAVD forms differ in terms of
loop dynamics in MD simulations, we analyzed a root mean
square fluctuation (RMSF), measuring main chain motion for a
10 ps time window (Figure 4). The analysis revealed that the
linkers connecting the original termini of the domains (Figure 1,
red linkers) were highly mobile, particularly in the avidin domain
(GGSGGS, residues 70–75 connecting the original termini). We
also detected regions behaving differently between the chimeric
dcAVD forms; for dcAVD/SA, there were unique mobile regions
in the loop between the strands b7 and b8 (residues 164–169) and
in the loop between the strands b4 and b5 (residues 243–249) that
corresponded to the potential electrostatic repulsion (Figure 3C
and 3D). Overall, however, no dramatic differences were observed
in the loop mobility between different dcAVD forms, suggesting
that there were no significant problems in the molecular design of
the chimeric dcAVDs.
The chimeric dcAVD/AVR4 showed an increase in
thermal stability when compared to dcAVD
A thermal stability assessment of the dcAVD/AVR4 by SDS-
PAGE revealed a significant improvement when compared to that
of dcAVD. The determined transition temperature of subunit
dissociation (Tr) was 25uC higher for dcAVD/AVR4 (Table 1).
The presence of D-biotin in the binding site stabilized the
dcAVD/AVR4 quaternary structure, and the determined transi-
tion temperature of oligomeric disassembly (Tr) increased from
65uCt o8 5 uC; however, when compared to dcAVD, the increase
in transition temperature due to ligand binding was less (Table 1).
Differential scanning calorimetry (DSC) was used to analyse the
thermodynamics of the heat-induced unfolding. In a DSC analysis
of dcAVD/AVR4, a two-phase melting profile was observed both
with and without biotin (Figure 5B). This melting profile was not
detected in the dcAVD samples, in which the heat induced
unfolding resulted in a single peak in the thermogram (Figure 5A).
The thermograms recorded with dcAVD/AVR4 samples were
deconvoluted in order to separate the two peaks (Figure 5C &
Figure 5D). The main peak in the dcAVD/AVR4 thermogram
revealed a melting point (Tm) at 91.3uC (Figure 5C), which is
about 11uC higher compared to that measured for dcAVD
(80.2uC). The smaller secondary peak showed a melting point at
86.3uC. In the presence of biotin, the main peak showed a melting
point at 112.3uC, and a secondary peak at 107.8uC (Figure 5D).
Interestingly, in the presence of biotin, dcAVD/AVR4 was
denatured at a lower temperature compared to the melting
temperature (115.9uC) of dcAVD. Overall, dcAVD/AVR4 had
improved thermal stability in the absence of biotin, but the
addition of biotin did not produce as significant thermal
stabilization as in the case of dcAVD or wt AVD. Therefore,
the exchange of the cp65-subunit of dcAVD with a circularly
permuted AVR4 subunit increased the thermal stability of the
chimeric fusion protein, while the other domain of the tandem
gene remained unchanged (AVD-derived cp54). The lower biotin-
binding affinity of the introduced AVR4-derived subunit reflected
the thermal stability of the whole fusion protein in the presence of
biotin. These results are clear indications of structural coopera-
tivity between the subunits of the tetramer during thermal
unfolding; however, previous studies have shown that (strept)avi-
din has relatively little or no structural cooperativity between
subunits [21–23]. One reason for the apparently low cooperativity
has been attributed to the subunit exchange between partially
unfolded proteins [24]. For dcAVD, the covalent attachment of
the subunits might block or at least significantly reduce the subunit
exchange in the thermal unfolding process. Therefore, the dual
chain concept allows a novel type of approach in studies
elucidating the unfolding mechanisms of avidin proteins. The
unfolding process was irreversible, which is typical for avidin
proteins.
The biotin-binding properties of dcAVD/AVR4 differed
from those of the parental proteins
Fluorescently labeled biotin and surface plasmon resonance
(SPR) biosensor were used to study the biotin-binding character-
istics of dcAVD/AVR4. In the experiment with fluorescently
labeled biotin a bi-phasic ligand-dissociation process was detected,
where roughly 50% of the protein subunits released biotin with
rapid (kdiss=1.1610
23 s
21) dissociation kinetics (Figure 6). It is
probable that the rapid biotin-dissociation phase was associated
with the AVR4-derived cp65 domain. As we have previously
shown, the biotin-binding affinity of the circularly permuted avidin
cp65 is slightly less than wt AVD. In contrast, the cp54 version
appears to behave more like wt AVD in terms of biotin-binding
[9]. The previous studies have shown that the AVR4 protein has a
slightly lower biotin-binding affinity (Kd=3.6610
214 M) than
avidin (Kd=1.1610
216 M) [25]; however, the measured increase
in the biotin dissociation rate of dcAVD/AVR4 was higher than
expected based on previous studies, possibly reflecting the
Chimeric Dual-Chain Avidin
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[26,27].
In the SPR analysis using the Biacore X instrument, the
biotin derivative 2–iminobiotin was coupled to the sensor chip
using amino-coupling chemistry. For the dcAVD/AVR4, we
measured an apparent equilibrium dissociation constant of
9.6610
26 M, which is greater than the constant measured for
the parental proteins (wtAVD Kd=1.2610
27 M, AVR4(C112S)
Kd=7.2610
27 M). The binding of dcAVD strongly resembled
the wtAVD that was analyzed in the SPR assay in our preceding
study [9].
The results from the fluorescent biotin interaction and the SPR
analyses were consistent with each other; however, for the SPR
measurements, the 2-iminobiotin ligand was attached onto the
surface, and therefore, the interaction between the immobilized
ligand and free protein was measured. For the measurements using
the fluorescently labeled biotin, the ligand moved freely in
solution. Therefore, SPR analysis could overestimate the binding
affinity of chimeric dcAVDs because the protein might preferably
bind the immobilized ligand with the subunit that has the greater
binding affinity.
The biotin-binding properties of dcAVD/AVR4 and those
measured for dcAVDs carrying point mutations in the biotin-
binding site [11] suggested that the modification of the loop
connecting beta strands 5 and 6 in the C-terminal domain of dual-
chain avidin had negative effects on biotin-binding. In both
studies, the dissociation rate constant for the C-terminal domain
(cp 65, see Figure 1) was decreased more than expected, based on
Figure 3. Interactions between the subunit interfaces of chimeric dcAVD fusions by MD simulation. The electrostatic interaction energy
was measured between the circularly permuted subunits in chimeric dcAVDs (A). The analysis was performed for both subunit pairs independently,
and the interaction energy is plotted over the 4-ns MD simulation. The van der Waals energy between subunits was measured during the simulation
time (B). The potential sources of electrostatic repulsion for dcAVD/SA were examined by visual inspection of the MD simulation data. Three clusters
of residues (D247-E15-D241, K12-R239 and D27-E165) potentially causing electrostatic repulsion between cpAVD and cpSA were detected. These
residues are shown in a liquorice representation (C, D). The figures were prepared using the program PyMOL (www.pymol.org) and numbered
according to Figure 1. All the calculations were performed with 5-ps resolution.
doi:10.1371/journal.pone.0020535.g003
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engineer the C-terminal domain of the dcAVD for novel
characteristics while preserving the wt AVD-like characteristics
of the N-terminal domain (cp54). This would exploit the
existing biotinylated molecular tools maximally in dcAVD-based
applications.
Conclusions
Dual-chain avidin is an example of the complicated genetic
engineering possible with the robust structure of avidin [9]. In the
current study, the usability of dcAVD was improved by creating
chimeric dual-chain avidin proteins. As a fusion partner with wt
AVD, we used three different proteins from the avidin protein
family: streptavidin, AVR2 and AVR4. The most successful was a
chimeric tandem fusion of circularly permutated wt AVD and
circularly permuted AVR4. Enhanced protein expression and
thermal stability resulted when compared to the original dcAVD.
Also, the PCR amplification was more straightforward when
using chimeric dual chain fusion. Closer analyses of dcAVD/
AVR4 protein showed that the molecule exhibited heterogenous
biotin-binding. This might be advantageous in applications where
two different biotin-binding affinities are needed. To further this
technique, the dcAVD/AVR4 format can be combined with
other genetically engineered avidins with modified or completely
Figure 4. Local dynamics in the chimeric dcAVD fusions measured by MD simulation. To probe the local structural dynamics, the root
mean square fluctuation (RMSF) per residue was measured for a short time window (10 ps) for the last 3 ns of the 4-ns MD simulation. The resulting
values were averaged and plotted in graphs A–C (A: dcAVD/AVR2; B: dcAVD/AVR4; C: dcAVD/SA). The dynamics of the structure are illustrated by
plotting 50 superimposed structural snapshots along the 4-ns simulation (D–F). The loops showing a high amount of structural fluctuation
(RMSF.1.5 A ˚) are indicated by numbers referring to the amino acid sequence (see also Figure 1). The structural snapshots are colored according to
timestep, as illustrated by the scale bar (please note that the color scale is illustrative only because of the rendering method). Figures D–F were
prepared using the program VMD 1.8.7 [35].
doi:10.1371/journal.pone.0020535.g004
Table 1. Transition temperatures of the subunit dissociation
(Tr) and thermal unfolding (Tm) determined by SDS-PAGE and
DSC.
SDS-PAGE DSC
Tr (6C) Tr
(+BTN) (6C) Tm (6C) Tm
(+BTN) (6C)
AVD 60
a 95
a 84
b 117
b
AVR4(C112S) 90 95 110
b 127
b
dcAVD 40 75
c 80
a 116
a
dcAVD/AVR4 70 85 86/91
d 108/112
d
aValue from [19];
b[25];
c[9];
d(two-peak analysis was applied to the data, and the minor peak is shown in
italics).
doi:10.1371/journal.pone.0020535.t001
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have been developed in our group by random mutagenesis and
selected by phage display (Riihima ¨ki et al., manuscript). By
combining these modified avidins to a dcAVD or single-chain
(scAVD, [28]) avidin platform, it will be possible to develop
avidin-based receptors with alternative binding affinities or with
multiple ligand specificities to be used in in vitro diagnostics or in
nanotechnology.
Materials and Methods
Evaluation of the PCR performance of the chimeric
dcAvd fusions
PCR amplification of the chimeric tandem fusion genes was
performed to evaluate their suitability for genetic modification.
The first PCR experiment was performed using four conditions;
the second PCR experiment was performed using two conditions
(Table S1). Pfu polymerase (Fermentas) was used and reactions
were performed following the manufacturer’s instructions. All
PCR products were analyzed by 1.5% agarose gel electrophoresis
using a 1-kbp DNA ladder as a standard.
Production of chimeric dcAVD fusion proteins
DNA constructs of circularly permutated avidin cp54 were
fused to circularly permuted streptavidin, AVR2 and AVR4 (cp65
SA/AVR2/AVR4) [9]. Circularly permuted genes were inserted
into the pBVboostFG plasmid containing the region encoding the
OmpA signal sequence, and the plasmid was transformed into
chemically competent E. coli TOP10 cells (Invitrogen) by the
standard heat-shock method. The plasmids were harvested using
the Qiagen Plasmid Miniprep kit according to the manufacturer’s
instructions, and the inserts were verified by DNA sequencing.
Figure 5. DSC analysis shows the biphasic thermal denaturation mode of the dcAvd/AVR4 protein. Heat-induced unfolding of the
proteins was analysed by differential scanning calorimetry. The measured thermogram of dcAVD (A) and dcAVD/AVR4 (B) is shown without and with
biotin (With Btn). Deconvoluted thermograms of dcAVD/AVR4 without (C) and with (D) biotin are also shown. The thermogram of dcAVD/AVR4
shows a melting point (Tm) at 91.3uC (C), which is about 11uC greater than for dcAVD (80.2uC, [11]). The smaller secondary peak shows a melting point
at 86.3uC. Biphasic thermal denaturation mode is also detected in the presence of biotin (D); the melting point of the main peak is at 112.3uC, and the
secondary peak is at 107.8uC. Interestingly, in the presence of biotin, dcAVD/AVR4 was denatured at a slightly lower temperature compared with
dcAVD 115.9uC [11].
doi:10.1371/journal.pone.0020535.g005
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cloning cassette are shown in Figure 1.
For protein production, the plasmids were transformed into E.
coli BL21-AI cells (Invitrogen) by the heat-shock method. After
overnight induction at 26uC, the avidin proteins were purified by
affinity chromatography on a 2-iminobiotin column (Affiland,
Lie `ge, Belgium) [19,29]. The avidin concentration was measured
with a NanoDrop
TM 3300 spectrometer using a molar absorption
coefficient (for dcAVD/AVR4; e=50 880 M
21 cm
21 and
M=29 045 g/mol, for dcAVD/AVR2; e=48 320 M
21 cm
21
and M=28 866 g/mol and for dcAVD/SA e=65 980 M
21
cm
21 and M=28 316 g/mol) at 280 nm. The produced hybrid
dcAVD proteins were analyzed by SDS-PAGE stained with
Coomassie Brilliant Blue.
Production of dcAvd/AVR4 by pilot-scale fermentation
For pilot-scale fermentation of dcAVD/AVR4 protein, the
Infors Labfors 3 fermentor was used. LB medium containing
gentamycin (7 mg/ml) and 0.1% glucose (w/v) was used for
fermentation, supplemented with antifoam agent struktol J647
(Schill & Seilacher, Hamburg, Germany). Overnight bacterial
culture in LB medium was used for inoculation. In the beginning
of fermentation, the pO2 of dissolved oxygen was 0%, stirring
speed 500 rpm and OD600 0.288. Fermentation was performed at
28uC. The level of oxygen was slowly raised to obtain 20%
dissolved oxygen (pO2). A feedback loop to maintain the oxygen
level at 20% was set by adjusting the stirring speed ranging from
150 to 1100 rpm. Pumping of the feed solution (50% glycerol,
2.5 g/l MgSO4, 33 ml/h) was initiated at OD,1. The induction
of protein production was performed at OD,1.5 by adding
0.25 mM IPTG (Fermentas) and 0.2% (w/v) L–arabinose (Sigma).
Induction was continued for 24 h. The cells were harvested by
centrifugation (50006g, 15 min, 20uC), lysed by sonication and
subjected to 2-iminobiotin affinity chromatography as previously
described [19].
Oligometric state of the produced chimeric dual chain
fusions
Size-exclusion chromatography was used to determine the
oligomeric state of the produced fusion proteins with an A ¨kta
Purifier P10 instrument (Amersham Biosciences) equipped with a
Tricorn
TM High Performance Column Superdex
TM 75 10/300
GL. A 50-mg sample of protein diluted in liquid phase (50 mM
NaPO4 pH 7, 650 mM NaCl) was used. Bio-Rad standard proteins
ranging from 1.5 to 67 kDa were used to calibrate the column.
Thermostability of dcAVD/AVR4 protein
For SDS-PAGE thermostability analysis, the purified proteins
were first in situ acylated [30]. Sulfosuccinimidyl acetate (Pierce
#26777) was used for protein acylation. D-biotin (140 mM) was
added to half the samples, and an equal volume of water was
added to the other half. Samples were diluted with SDS- and 2-
mercaptoethanol-containing sample buffer and incubated at
different temperatures (without biotin: RT (20–22uC), 40uC,
50uC, 60uC, 70uC, 100uC; with biotin: RT, 70uC, 80uC, 90uC,
100uC) for 20 min. After incubation, the samples were analyzed
by SDS-PAGE stained with Coomassie Brilliant Blue. Thermo-
stability of AVR4(C122S) protein was also determined. The
temperatures used for AVR4(C122S) protein were without biotin:
RT, 60uC, 70uC, 80uC, 90uC, 100uC; and with biotin: RT, 80uC,
90uC, 100uC, 120uC.
The thermodynamics of dcAVD/AVR4 unfolding was char-
acterized by differential scanning calorimetry (DSC) [31]. In the
DSC measurements, wt dcAVD was used as a control. The
Figure 6. Determination of ligand dissociation kinetics with a fluorescent-biotin conjugate. The dissociation of fluorescently labeled
biotin from various avidin forms was studied by replacing the labeled biotin with an excess of free biotin. AVD, AVR4(C122S) and dcAVD showed a
slow dissociation. For dcAVD/AVR4, a clearly biphasic dissociation process was observed. The analysis of the first part of the measurement (0–300 s,
inset) reveals an estimate for the dissociation rate constant of 1.13610
23 s
21 for the rapid dissociation phase of dcAVD/AVR4, which is about 1006
greater when compared to avidin or AVR4(C122S).
doi:10.1371/journal.pone.0020535.g006
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(pH 7.0) containing 100 mM of sodium chloride. The temperature
was increased from 20 to 130uC with a 1uC/min heating rate.
Determination of the dissociation rate constant of
fluorescent biotin
The dissociation rate constant of conjugated biotin was
examined by fluorescence spectroscopy using fluorescently labeled
biotin (Bf560–BTN, Arcdia, Turku, Finland). A 50-nM biotin-
fluorochrome solution diluted in 50 mM sodium phosphate buffer
(pH 7.0) containing 650 mM of sodium chloride was mixed with
the protein solution (50 nM or 100 nM), followed by incubation
(5 min). The dissociation process was illuminated by adding 100-
fold excess of D-biotin (5 mM), which was measured after 1 hour.
The measurements were performed at 25uCo r5 0 uC with
QuantaMaster Spectrofluorometer System equipped with thermo-
stated water bath [19].
Determination of 2-iminobiotin binding kinetics by
surface plasmon resonance biosensor analysis
The SPR analysis was performed for wt AVD, dcAVD/AVR4
and AVR4 proteins. The CM5 chips functionalized with 2-
iminobiotin were used for the interaction analysis. The Biacore X
instrument (GE Healthcare) was used and the measurements were
performed at 25uC using 50 mM sodium carbonate buffer (pH 11)
containing 1 M of sodium chloride as the running buffer. The
kinetic data were calculated from the sensograms using Langmuir-
ian binding model implemented in the BIAevaluationH program.
Molecular modeling and molecular dynamics simulations
The predicted models of chimeric dual-chain fusion proteins
were generated by exploiting the existing 3-D structures of dcAVD
(PDB 2C4I), SA (PDB 1MK5), AVR2 (PDB 1WBI) and AVR4
(PDB 1Y53) as templates. The sequence forming the cp65-subunit
of dcAVD (PDB 2C4I) was first replaced with a corresponding
sequence from another protein that had its sequence reorganized
equally (for details, see Figure 1 and [9]). The program Modeller
9v2 [32] was then used to generate a homology model of the
pseudodimer. Structural water molecules were included according
to their template structures, and the following structures were also
used to position the structural water molecules: PDB 1SLF, PDB
1AVE, and PDB 2AVI. The pseudotetrameric forms were then
generated by positioning two pseudodimers by structural super-
imposition with BODIL [33]. The generated homology models
were subjected to molecular dynamics simulation using the
program NAMD 2.6 and the CHARMM22 force field [34]. First,
the models (including structural waters extracted from PDB-files)
were placed in a box filled with TIP3 waters (box size
approximately 80 A ˚680 A ˚670 A ˚) using the SOLVATE algo-
rithm in the program VMD 1.8.6 [35]. Na
+ or Cl
2 ions were
added to neutralize the system. The complete systems contained
58377 (dcAVD/AVR4), 56803 (dcAVD/AVR2), and 53207
(dcAVD/SA) atoms. The systems were then subjected to
minimization as follows: the first minimization was performed by
fixing all the protein atoms and allowing water molecules to move
according to minimization procedure implemented in NAMD for
4000 steps. The second 4000 step minimization was performed by
releasing all the atoms in the system except Ca atoms. Finally, the
system was minimized without constraints for 4000 steps.
The minimized system was thermalized by increasing the
temperature to 310 K in 31 ps with a Berendsen barostat (1 atm).
This step was followed by the production of the coordinate
trajectories under NPT conditions using the Berendsen barostat (1
atm) and the Berendsen thermostat at 310 K. The resulting data
were analyzed using the programs VMD 1.8.7, PyMOL 1.3, and
MS Excel 2010. RMSF calculations were run such that the Ca
atoms of one peptide chain were first aligned, and RMSF
(deviation over the last 10 ps) values were calculated for the Ca
atoms of the aligned chain. RMSF values were taken every 5 ps for
the last 3 ns of equilibration (600 time points) and averaged. The
force-field interaction energies between domains of dcAVDs were
calculated from the simulation trajectories by the NAMD 2.7
program using 5-ps time step.
Supporting Information
Figure S1 Oligomeric state of the dcAVD/AVR4 protein
determined by gel filtration. Gel-filtration chromatography
analysis showed a main peak corresponding to a dimeric (pseudo-
tetrameric) dcAVD/AVR4(estimated molecular weight of 46 kDa).
Additionally, some higher molecular weight species are detected.
(TIF)
Figure S2 The SDS-PAGE analysis of the pilot-scale
production and the 2-iminobiotin purification of the
dcAVD/AVR4 protein. A Labfors Infors 3 bioreactor was used
for a pilot-scale production of the dcAVD/AVR4 protein. The
pilot-scale fed-batch fermentation in standard LB medium yielded
over 5 mg of the pure dcAVD/AVR4 protein per liter of
production medium. A, chicken avidin (10 mg); T, total sample
from culture; L, unbound fraction after incubation with 2-
iminobiotin; f2–f17 samples of elution fractions. The PageRuler
TM
Plus prestained protein ladder (Fermentas) was used as a molecular
weight standard.
(TIF)
Table S1 Conditions used in the PCR amplification
analysis. In the first PCR experiment, four conditions were used
by varying annealing and elongation times. In the second PCR
experiment, two different conditions were used as described in the
table.
(DOC)
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